Literature DB >> 15985785

Complications in smokers after postmastectomy tissue expander/implant breast reconstruction.

Susie J Goodwin1, Colleen M McCarthy, Andrea L Pusic, Duc Bui, Michael Howard, Joseph J Disa, Peter G Cordeiro, Babak J Mehrara.   

Abstract

Smoking is universally considered to be a risk factor for surgical complications. The incidence of complications following tissue expander/implant breast reconstruction in patients who smoke has not been previously evaluated.A review of complications following tissue expander/implant reconstruction in 515 patients was performed. Patients who had 2-stage, tissue expander/implant reconstruction at Memorial Sloan-Kettering Cancer Center between May 2002 and December 2003 were included. Complications in smokers (n=132) and nonsmokers (n=383) were compared. The rate of overall complications, reconstructive failure, mastectomy flap necrosis, and infectious complications was significantly higher in smokers compared with nonsmokers. The rate of complications in ex-smokers was also higher than in nonsmokers. Using multivariate statistical analysis to adjust for confounding variables, smoking was identified as independent predictor of postoperative complications.A significant association between smoking status and postoperative complications exists. Thus, smokers who undergo postmastectomy expander/implant reconstruction should be informed of the increased risk of surgical complications and should be counseled on smoking cessation.

Entities:  

Mesh:

Year:  2005        PMID: 15985785     DOI: 10.1097/01.sap.0000168282.81348.b3

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  21 in total

Review 1.  Breast reconstruction following conservative mastectomies: predictors of complications and outcomes.

Authors:  Sophocles H Voineskos; Simon G Frank; Peter G Cordeiro
Journal:  Gland Surg       Date:  2015-12

2.  [Effect of cigarette smoking on skin perfusion of the hand].

Authors:  F T Petschke; T O Engelhardt; H Ulmer; H Piza-Katzer
Journal:  Chirurg       Date:  2006-11       Impact factor: 0.955

Review 3.  Effects of preoperative smoking cessation on the incidence and risk of intraoperative and postoperative complications in adult smokers: a systematic review.

Authors:  Alice Theadom; Mark Cropley
Journal:  Tob Control       Date:  2006-10       Impact factor: 7.552

Review 4.  Current opinions on indications and algorithms for acellular dermal matrix use in primary prosthetic breast reconstruction.

Authors:  Michael M Vu; John Y S Kim
Journal:  Gland Surg       Date:  2015-06

5.  Tobacco assessment in actively accruing National Cancer Institute Cooperative Group Program Clinical Trials.

Authors:  Erica N Peters; Essie Torres; Benjamin A Toll; K Michael Cummings; Ellen R Gritz; Andrew Hyland; Roy S Herbst; James R Marshall; Graham W Warren
Journal:  J Clin Oncol       Date:  2012-06-11       Impact factor: 44.544

6.  Two-Stage Implant-Based Breast Reconstruction: An Evolution of the Conceptual and Technical Approach over a Two-Decade Period.

Authors:  Peter G Cordeiro; Leila Jazayeri
Journal:  Plast Reconstr Surg       Date:  2016-07       Impact factor: 4.730

7.  Accuracy of self-reported tobacco use in newly diagnosed cancer patients.

Authors:  Nelson A Morales; Michelle A Romano; K Michael Cummings; James R Marshall; Andrew J Hyland; Alan Hutson; Graham W Warren
Journal:  Cancer Causes Control       Date:  2013-04-04       Impact factor: 2.506

8.  Delayed two-stage breast reconstruction with implants: The authors' recent experience.

Authors:  Jan Rykała; Paweł Szychta; Julia Kruk-Jeromin
Journal:  Can J Plast Surg       Date:  2011

9.  Nicotine and lung cancer.

Authors:  Graham W Warren; Anurag K Singh
Journal:  J Carcinog       Date:  2013-01-31

10.  Preoperative β-lactam antibiotic prophylaxis is superior to bacteriostatic alternatives in immediate expander-based breast reconstruction.

Authors:  Travis J Miller; Austin C Remington; Dung H Nguyen; Geoffrey C Gurtner; Arash Momeni
Journal:  J Surg Oncol       Date:  2021-07-08       Impact factor: 2.885

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.